Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00108927 · ClinicalTrials.gov registry record

Improving Diabetes in Primary Care (IMPACT)

A clinical trial of Hypertension and Diabetes Mellitus, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).

Completed
Registry status
6,000
Enrollment target
1
Study location

NCT00108927 is a study of Hypertension and Diabetes Mellitus that has completed, run by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). The registered enrollment target is 6,000 participants, above the 3,495-participant average among 470 other Hypertension trials with a reported enrollment target (72% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00108927, a study of Hypertension and Diabetes Mellitus, has completed, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).

COMPLETED
Registry status
6,000 participants
Enrollment target
1
Study location

Study Summary

The goal of our research program is to successfully translate empirical knowledge regarding diabetes treatment and management into sustainable clinical practice. The study hypothesis is that implementation of a multicomponent intervention will result in meaningful improvement in clinical performance measures at the clinic that include average A1c (Hemoglobin A1c), average systolic blood pressure, and national clinical performance measures at a reasonable cost to the health system.

Interventions

  • BEHAVIORAL TRANSLATE

Study Locations (1)

Minnesota

  • Dept of Family Medicine and Community Health, University of Minnesota Medical School - Minneapolis

Trial Details

FieldValue
Enrollment Target 6,000 participants
Start Date 2003-12
Est. Completion 2005-12

What the Registry Record Tells You About NCT00108927

The ClinicalTrials.gov registry entry for NCT00108927 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 6,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 3,495-participant average among 470 other Hypertension trials with a reported enrollment target (72% higher). The listed sponsor is National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), which has 490 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Hypertension appearing as the primary indexed condition, and to 1 intervention - of which TRANSLATE is the first listed.

NCT00108927 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT00108927 about?

NCT00108927 is a clinical study titled "Improving Diabetes in Primary Care (IMPACT)". The goal of our research program is to successfully translate empirical knowledge regarding diabetes treatment and management into sustainable clinical practice. The study hypothesis is that implementation of a multicomponent intervention will result in meaningful improvement in clinical performance...

What is the current status of trial NCT00108927?

This trial is currently completed. The enrollment target is 6,000 participants. The study started on 2003-12. Estimated completion is 2005-12.

What conditions does trial NCT00108927 study?

This clinical trial studies the following conditions: Hypertension, Diabetes Mellitus, Type 2 Diabetes Mellitus.

What interventions are being tested in trial NCT00108927?

The interventions under investigation include: TRANSLATE (BEHAVIORAL).

Who is sponsoring clinical trial NCT00108927?

This trial is sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), which has 490 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00108927 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.